Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Executives Sell More Than $262M Of 5 Stocks

Published 04/04/2022, 18:06
Updated 04/04/2022, 18:40
© Reuters.  Executives Sell More Than $262M Of 5 Stocks
IXIC
-
REGN
-
GTES
-
NFE
-
REGN34
-

Although gold futures traded higher on Monday, there were a few notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Regeneron Pharmaceuticals

  • The Trade: Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Director P. Roy Vagelos sold a total of 28,572 shares at an average price of $700.01. The insider received around $20 million from selling those shares.
  • What’s Happening: BioNTech recently expanded its strategic collaboration with Regeneron Pharmaceuticals to its FixVac candidate BNT116 combined with Libtayo (cemiplimab) in advanced non-small-cell lung cancer (NSCLC).
  • What Regeneron Pharmaceuticals Does: Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.
Horizon Therapeutics
  • The Trade: Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) Chairman, President and CEO Timothy Walbert sold a total of 50,000 shares at an average price of $105.26. The insider received around $5.26 million from selling those shares.
  • What’s Happening: Horizon Therapeutics, last month, said that the U.S. FDA granted priority review of the supplemental Biologics License Application (sBLA) to expand the label for KRYSTEXXA plus methotrexate, an immunomodulator commonly prescribed by rheumatologists.
  • What Horizon Therapeutics Does: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company.
Also check this: Insiders Buying These 4 Penny Stocks

ZoomInfo Technologies

  • The Trade: ZoomInfo Technologies Inc. (NASDAQ: ZI) 10% owner Cp Vi Evergreen Holdings Lp sold a total of 184,693 shares at an average price of $59.24. The insider received around $10.94 million as a result of the transaction.
  • What’s Happening: ZoomInfo, last month, announced plans to open new office near Tel Aviv, Israel.
  • What ZoomInfo Technologies Does: ZoomInfo Technologies Inc provides a go-to-market intelligence platform for sales and marketing teams.
Have a look at our premarket coverage here .

Gates Industrial Corporation

  • The Trade: Gates Industrial Corporation plc (NYSE: GTES) 10% owner Stephen Schwarzman sold a total of 13,750,000 shares at an average price of $15.14. The insider received around $208.18 million from selling those shares.
  • What’s Happening: Barclays (LON:BARC) maintained Gates Industrial with an Equal-Weight and lowered the price target from $17 to $16.
  • What Gates Industrial Does: Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. It offers a portfolio of products to diverse replacement channel customers, and to original equipment manufacturers.
New Fortress Energy
  • The Trade: New Fortress Energy Inc. (NASDAQ: NFE) 10% owner Jonathan Rotolo sold a total of 400,000 shares at an average price of $44.86. The insider received around $17.95 million from selling those shares.
  • What’s Happening: Stifel maintained New Fortress Energy with a Buy and raised the price target from $45 to $68.
  • What New Fortress Energy Does: New Fortress Energy Inc is an integrated gas-to-power company. The company is mainly engaged in providing modern infrastructure solutions to create cleaner, reliable energy while generating a positive economic impact.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.